Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Quantification of preexisting lung ground glass opacities on CT for predicting checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients

Fig. 2

Examples of pulmonary lobe segmentation and opacity segmentation (A, B), pretreatment CT images of a patient with ground glass opacity, the patient developed grade 3 CIP at 133 days after ICI treatment. (C, D), pretreatment CT images of a patient with ground glass opacity, the patient developed grade 1 CIP at 118 days after ICI treatment. (E, F) pretreatment CT images of a patient with fibrosis, the patient did not develop CIP after ICI treatment

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us